Free Trial
NASDAQ:NRBO

NeuroBo Pharmaceuticals (NRBO) Stock Price, News & Analysis

NeuroBo Pharmaceuticals logo
$0.61 -0.03 (-4.65%)
As of 07/30/2025

About NeuroBo Pharmaceuticals Stock (NASDAQ:NRBO)

Key Stats

Today's Range
$0.60
$0.64
50-Day Range
$0.61
$0.79
52-Week Range
$2.08
$4.41
Volume
60,900 shs
Average Volume
39,605 shs
Market Capitalization
$5.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NRBO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

NRBO Stock News Headlines

This New Rule Could Change Everything
A major change is quietly going into effect this July — and Wall Street is already positioning for it. Big Banks have found a way to use a new asset as if it were cash. Not stocks. Not bonds. Not even the U.S. dollar. They now trust this asset more than the traditional financial system itself.
NeuroBo Pharmaceuticals Rebrands Amidst Strategic Changes
NeuroBo Pharmaceuticals announces relignment, change name
See More Headlines

NRBO Stock Analysis - Frequently Asked Questions

NeuroBo Pharmaceuticals' stock was trading at $2.03 on January 1st, 2025. Since then, NRBO stock has decreased by 70.2% and is now trading at $0.6051.

NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) posted its quarterly earnings data on Thursday, November, 7th. The company reported ($0.55) earnings per share for the quarter, beating analysts' consensus estimates of ($0.82) by $0.27.

NeuroBo Pharmaceuticals shares reverse split before market open on Thursday, December 21st 2023.The 1-8 reverse split was announced on Thursday, December 21st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, December 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

Shares of NRBO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that NeuroBo Pharmaceuticals investors own include Meta Platforms (META), NVIDIA (NVDA), Broadcom (AVGO), CymaBay Therapeutics (CBAY), CrowdStrike (CRWD), GE Aerospace (GE) and Adobe (ADBE).

Company Calendar

Last Earnings
11/07/2024
Today
8/01/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Banking
Current Symbol
NASDAQ:NRBO
CIK
1638287
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.47 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-189.12%
Return on Assets
-122.31%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.41
Quick Ratio
2.41

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.50 per share
Price / Book
0.40

Miscellaneous

Outstanding Shares
8,616,000
Free Float
8,526,000
Market Cap
$5.21 million
Optionable
Not Optionable
Beta
-0.26

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:NRBO) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners